T1	Concept 0 6	7 mNGS
T2	Concept 16 24	settings
T3	Concept 10 15	field
R1	has-property Arg1:T2 Arg2:T3	
R2	in-context Arg1:T1 Arg2:T2	
T4	Concept 32 40	critical
R3	has-property Arg1:T1 Arg2:T4	
T5	Action 44 55	development
T6	Concept 59 74	countermeasures
T7	Concept 83 92	2014-2016
T8	Concept 105 113	epidemic
T9	Concept 93 104	Ebola virus
R4	in-context Arg1:T8 Arg2:T9	
T10	Concept 117 128	West Africa
R5	in-place Arg1:T8 Arg2:T10	
R6	in-time Arg1:T8 Arg2:T7	
R7	in-context Arg1:T6 Arg2:T8	
R8	target Arg1:T5 Arg2:T6	
R9	in-context Arg1:T4 Arg2:T5	
T11	Action 146 156	sequencing
T12	Concept 160 168	COVID-19
T13	Concept 169 174	cases
R10	in-context Arg1:T13 Arg2:T12	
T14	Concept 197 202	areas
T15	Concept 180 196	lesser developed
R11	has-property Arg1:T14 Arg2:T15	
T16	Concept 206 220	Southeast Asia
R12	in-place Arg1:T14 Arg2:T16	
R13	target Arg1:T11 Arg2:T13	
R14	in-place Arg1:T11 Arg2:T14	
T17	Action 248 261	understanding
T18	Concept 240 247	overall
R15	has-property Arg1:T17 Arg2:T18	
R16	causes Arg1:T11 Arg2:T17	
T19	Concept 265 273	pathogen
T20	Action 274 286	transmission
T21	Concept 288 294	origin
T22	Action 300 309	evolution
R17	subject Arg1:T20 Arg2:T19	
R18	subject Arg1:T22 Arg2:T19	
R19	in-context Arg1:T21 Arg2:T19	
R20	target Arg1:T17 Arg2:T20	
R21	target Arg1:T17 Arg2:T21	
R22	target Arg1:T17 Arg2:T22	
T23	Concept 342 346	mean
T24	Concept 351 357	median
T25	Concept 331 341	incubation
R23	in-context Arg1:T23 Arg2:T25	
R24	in-context Arg1:T24 Arg2:T25	
T26	Concept 361 369	COVID-19
R25	in-context Arg1:T25 Arg2:T26	
T27	Concept 374 378	5.84
T28	Concept 387 391	days
T29	Concept 383 386	5.0
R26	in-context Arg1:T29 Arg2:T28	
R27	in-context Arg1:T27 Arg2:T28	
*	same-as T23 T27
*	same-as T24 T29
T30	Concept 611 619	positive
T31	Action 631 640	detection
T32	Concept 620 630	SARS-CoV-2
R28	target Arg1:T31 Arg2:T32	
R29	has-property Arg1:T31 Arg2:T30	
T33	Concept 653 662	specimens
T34	Concept 644 652	clinical
R30	has-property Arg1:T33 Arg2:T34	
T35	Concept 672 695	upper respiratory tract
R31	in-place Arg1:T33 Arg2:T35	
R32	in-context Arg1:T31 Arg2:T33	
T36	Concept 761 772	differences
A1	Negated T36
R33	is-a Arg1:T31 Arg2:T36	
T37	Concept 781 785	SARS
T38	Concept 790 798	COVID-19
T40	Concept 811 829	clinical pathology
R36	in-context Arg1:T36 Arg2:T40	
R34	in-context Arg1:T36 Arg2:T37	
R35	in-context Arg1:T36 Arg2:T38	
T39	Concept 856 871	interferon-MAPK
T41	Concept 872 889	signaling pathway
R37	in-context Arg1:T41 Arg2:T39	
T42	Action 917 925	response
T43	Concept 904 916	blood immune
R38	has-property Arg1:T42 Arg2:T43	
T44	Concept 930 938	COVID-19
T45	Action 939 948	infection
R39	subject Arg1:T45 Arg2:T44	
R40	in-context Arg1:T42 Arg2:T45	
R41	is-a Arg1:T41 Arg2:T42	
